ArticleMedicine and pharmacy reports2026

Untargeted serum metabolomics reveals metabolic signatures distinguishing basal cell carcinoma risk groups: an exploratory analysis.

Amalia Moisoiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.